Live Breaking News & Updates on Lindsey rodger

Stay informed with the latest breaking news from Lindsey rodger on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lindsey rodger and stay connected to the pulse of your community

BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES

BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Switzerland , Swiss , Toshisada-matsuba , David-clair , Michael-yang , Stephen-ross , Matt-mcmanus , Lindsey-rodger , Gaurav-joshi

LUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH WITH THE LAUNCH OF THE FIRST FULLY AUTOMATED, SAME-SECTION, HYPERPLEX MULTIOMICS APPLICATION

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will...

Florida , United-states , Orlando , Kim-kelderman , David-clair , Lindsey-rodger , Bio-techne-corporation , Facebook , Head-of-communications , Investor-relations-corporate-development , Linkedin , Advanced-cell-diagnostics

LUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP INNOVATIVE AI-BASED ASSAY DEVELOPMENT TOOLS

MINNEAPOLIS, Dec. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation today announced that Lunaphore, a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics, have been awarded Innosuisse funding...

Switzerland , Swiss , Aitana-neves , Kim-kelderman , Lindsey-rodger , David-clair , Head-of-communications , Facebook , Clinical-bioinformatics-group , Bio-techne-corporation , Investor-relations-corporate-development , Team-lead-data-science

Ferring Pharmaceuticals Announces Changes to Board of Directors

Ferring Pharmaceuticals Announces Changes to Board of Directors
cadillacnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cadillacnews.com Daily Mail and Mail on Sunday newspapers.

Georgia , United-states , Switzerland , Lindsey-rodger , Eva-paulsen , Lars-rebien , Frederik-paulsen , Novo-nordisk , Instagram , Mars-inc , Linkedin , Twitter

Ferring Pharmaceuticals: Ferring Presents New Data at ESHRE 2021 Supporting the Use of Rekovelle (follitropin delta) for Individualized Fertility Treatment

Ferring Pharmaceuticals: Ferring Presents New Data at ESHRE 2021 Supporting the Use of Rekovelle (follitropin delta) for Individualized Fertility Treatment
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Taiwan , Japan , United-states , China , Vietnam , Republic-of , Peking , Beijing , South-korea , Jie-qiao , Hunan , Switzerland

Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection

Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented results from the pivotal Phase 3 PUNCH™ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) over placebo. RBX2660 is an investigational, potential first-in-class microbiota-based live biotherapeutic

Switzerland , Vancouver , British-columbia , Canada , United-states , American , Lindsey-rodger , Lee-jones , Heather-guzzi , Courtney-jones , Paul-feuerstadt , Christine-lee

Ferring Pharmaceuticals: Ferring and Rebiotix Present Positive Interim Phase 3 Results From Open-Label Study of Investigational Microbiota-Based Live Biotherapeutic RBX2660 at Digestive Disease Week (DDW)

Ferring Pharmaceuticals: Ferring and Rebiotix Present Positive Interim Phase 3 Results From Open-Label Study of Investigational Microbiota-Based Live Biotherapeutic RBX2660 at Digestive Disease Week (DDW)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland , United-states , American , Lindsey-rodger , Colleen-kraft , Kostenloser-wertpapierhandel , Heather-guzzi , Courtney-jones , Ken-blount , James-tursi , Instagram , American-society-for-gastrointestinal-endoscopy

Ferring Pharmaceuticals: Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection

Ferring Pharmaceuticals: Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection
(DDW)
RBX2660 is the first microbiota-based live biotherapeutic to demonstrate efficacy as early as first recurrence of Clostridioides difficile (C. difficile) infection
RBX2660 Phase 3 data add to the world's largest and most robust clinical program ever conducted in the field of microbiome-based therapeutics
Findings build on previous RBX2660 clinical trials showing repeated efficacy and consistent safety, including two trials with two years of safety follow-up
Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented results from the pivotal Phase 3 PUNCH CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of

Vancouver , British-columbia , Canada , Switzerland , United-states , American , Lindsey-rodger , Lee-jones , Kostenloser-wertpapierhandel , Heather-guzzi , Courtney-jones , Paul-feuerstadt

Ferring Pharmaceuticals: Ferring and Rebiotix to Present Landmark Data for Investigational Microbiota-based Live Biotherapeutic RBX2660 at Digestive Disease Week (DDW) 2021

Ferring Pharmaceuticals: Ferring and Rebiotix to Present Landmark Data for Investigational Microbiota-based Live Biotherapeutic RBX2660 at Digestive Disease Week (DDW) 2021
Clostridioides difficile Infection With and Without Sepsis
Presenting Author: Alpesh Amin, MD, MBA, Thomas Mary Cesario Chairman, Department of Medicine, Executive Director, Hospitalist Program, University of California Irvine
EMBARGOED UNTIL PRESENTATION TIME: FRIDAY, MAY 21 AT 12:15 PM ET
DDW has made abstracts available on their website.
About RBX2660
RBX2660 is a potential first-in-class microbiota-based live biotherapeutic being studied to deliver a broad consortium of diverse microbes to the gut to reduce recurrent
C. difficile infection. RBX2660 has been granted Fast Track, Orphan, and Breakthrough Therapy designations from the U.S. Food and Drug Administration (FDA). The pivotal Phase 3 program builds on nearly a decade of research with robust clinical and microbiome data collected over six controlled clinical trials with more than 1,000 participants.

Switzerland , United-states , American , Heather-guzzi , Courtney-jones , Lindsey-rodger , Lee-jones , Thomas-mary-cesario , Kostenloser-wertpapierhandel , Colleen-kraft , Alpesh-amin , Christine-lee

Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health

Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Lindsey-rodger , David-daboush , Ken-blount , Mybiotic-mycrobe , Instagram , Linkedin , Microbiome-research , Twitter , S-national-library-of-medicine , Ferring-pharmaceuticals , Mybiotics-pharma-ltd